Literature DB >> 18462245

Case report of uncontrollable pelvic bleeding--managed by a previously unreported method (QuikClot).

V Shanmugam1, M H Robinson.   

Abstract

Pelvic haemorrhage can be difficult to control. Several measures including packing, drawing pins, stenting and embolization are available. We present a case where these measures failed to control catastrophic pelvic bleeding while operating in the pelvis to excise a dumbbell tumour involving the right S1 nerve root. Attempted surgical control by a vascular surgeon and radiological control through stenting and embolization failed to control the bleeding. QuikClot is an inert substance and acts as a selective sponge. This product is licensed for external use by the British military. We felt that 'internal' use of Quikclot in this situation might be lifesaving and was applied to the bleeding area, stopping the bleeding immediately.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462245     DOI: 10.1111/j.1463-1318.2008.01550.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  3 in total

1.  A hydrogel sealant for the treatment of severe hepatic and aortic trauma with a dissolution feature for post-emergent care.

Authors:  Marlena D Konieczynska; Juan C Villa-Camacho; Cynthia Ghobril; Miguel Perez-Viloria; William A Blessing; Ara Nazarian; Edward K Rodriguez; Mark W Grinstaff
Journal:  Mater Horiz       Date:  2016-12-23       Impact factor: 13.266

2.  Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation.

Authors:  V A Bonello; A Bhangu; J E F Fitzgerald; S Rasheed; P Tekkis
Journal:  Tech Coloproctol       Date:  2014-06-03       Impact factor: 3.781

3.  Prospective Randomized Controlled Study of Hemostatic Efficacy with Kaolin-Impregnated Dressings in Diabetic Foot Ulcers Taking Anticoagulants Undergoing Debridement in an Outpatient Clinic.

Authors:  Yeok Gu Hwang; Jin Woo Lee; Eun Ae Won; Seung Hwan Han
Journal:  J Diabetes Res       Date:  2019-11-11       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.